See other companies on Welcome to the Jungle

NeuralFrame

AI powered medical registry software platform

NeuralFrame logo
1-20 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • SaaS
  • Data Analysis
Greenwich, CT

Company mission

To use the power of AI to synthesise multiple sources of medical data, delivering smarter, faster, and deeper information to Clinicians, Researchers, and Administrators.

Our take

The global AI market within the healthcare sector is expected to grow an impressive 40.2% by 2029. The strain put on healthcare systems from the pandemic has resulted in a monumental backlog in services, and automated, efficient solutions are welcomed now more than ever. NeuralFrame is a software company dedicated to revolutionising the medical field through the application of AI, NLP, and machine learning. The company grapples to advance research, develop therapies, and administer patient care via it's registry software platform.

Boasting extensive knowledge in medical language models and extending existing medical ontologies, the company uses this knowledge to power its KACI platform, a cancer registry software platform that offers both patients and physicians simplified cancer facility operations, from enhancing accuracy and efficiency in Casefinding to Reporting. With the expansion of the healthcare IT sector we’re seeing increased investments and rising intrigue toward information technology. This places NeuralFrame at an advantage for its future and as the company wishes to start scaling beyond oncology it will be exciting to see how the platform will be adopted by more customers in the medical field.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Benefits

  • Dental insurance
  • Health insurance
  • Life insurance
  • Vision insurance

Company values

  • Adaptive
  • Innovative
  • Meticulous
  • Collaborative
  • Patient-Centric

Leadership

Patrick McNeillie

(Chief Information Officer)

Worked for several years at IBM Watson, most recently as Clinical Lead for IBM Watson Genomics.

Kevin Scanlan

(Head of Product Development)

Previously worked as a Project Manager at IBM Watson and Financial Analyst at Discovery Capital.